Literature DB >> 27843472

Sciatic Nerve Injection Palsy in Children.

Viraat Harsh1, Romy B Chengazhacherril2, Kanika Sharma3, Piyush Kalakoti3, Utkarsh Gupta4, Waqar Ahmad1, Anil Kumar1.   

Abstract

Entities:  

Year:  2016        PMID: 27843472      PMCID: PMC5100043     

Source DB:  PubMed          Journal:  Iran J Child Neurol        ISSN: 1735-4668


× No keyword cloud information.
Dear Editor-in-Chief We read with interest the article by Toopchizadeh et al.(1) reporting outcomes in pediatric patients with Sciatic Nerve Injection injury (SNII) following gluteal injection. Despite the commendable efforts of the authors in long-term monitoring of outcomes in these select cohort of patients with SNII using appropriate electro-diagnostic studies, supplemented use of advanced imaging techniques such as Magnetic Resonance (MR) Neurography to note for structural changes, and diffusion tensor tractography (DTT) for functional altercation, if at all, would have been worth exploring, especially in a setting where the utility of the former in pediatric patients may be limited by poor tolerance (2). The fractional anisotropy (FA) value, a parameter of DTT, is often considered a predictor of functional improvement and a prognostic indicator of nerve injury (3, 4). The authors plausibly attribute to the thickness of subcutaneous tissue and gluteal musculature as predisposing factors for SNII in pediatric age group. Other pertinent etiologic factors warranting consideration include but are not limited to needle angulation, site of injection, level of training, and patient posturing. Toopchizadeh et al. meticulously describe known factors such as chemical neurotoxicity, neural ischemia, allergic neuritis, anatomic variations, external scar formation, free radical damage as contributing factors to SNII in a context where injection delivery technique is apropos. Interestingly, other likely factors to impact degree of nerve injury constitute injection pressure, vehicle of suspension, choice of needle and its length, and volume of the injectable (5). Green smith et al. (6) highlight that high-pressure injections (>11psi) cause severe nerve bundle injury as compared to low-pressure injections. Erroneous practices often encountered while administering intramuscular injections amongst healthcare providers, and preventive measures to minimize them are well depicted by Barry and colleagues (7). Interestingly, all patients in the study were managed conservatively via physiotherapy and splints. Villarejo et al. (8) demonstrated excellent results following surgical intervention within 3-6 months of nerve injury. Tailoring surgical intervention for cases with minimal or no improvement as noted in clinical assessments or electrophysiologic studies after 3-6 months would have been appropriate. Surgical exploration along with nerve action potential (NAP) recording can be considered as a viable option even in cases with no significant recovery following 3-6 months of conservative management (9, 10). The authors suggest that the prognosis depends on the severity of the primary lesion, however other contributing factors including, but not limited to, are the division involved, level of injury, age of the lesion, timing of repair, patient’s comorbid index (11), and presence of CMAP in the Extensor Digitorum Brevis. Bay suggested that in cases where pain is the only symptom, SNII is fully reversible and the course of recovery may be influenced by psychological factors as well (12). Considering the disabling impact of SNII on quality of life (QoL), we recommend preventive measures aimed to at decreasing the incidence of SNII in children. Systematic and schematic training of healthcare providers with respect to the site of gluteal injection (anterolateral), needle angulation for intramuscular route, adequate pressure for flushing the injectable, and prompt identification of possible complications following gluteal injection and measures to mitigate them.
  10 in total

Review 1.  Surgery for peripheral nerve and brachial plexus injuries or other nerve lesions.

Authors:  R J Spinner; D G Kline
Journal:  Muscle Nerve       Date:  2000-05       Impact factor: 3.217

2.  [Injection injury to the sciatic nerve].

Authors:  E BAY
Journal:  Dtsch Med Wochenschr       Date:  1961-03-24       Impact factor: 0.628

3.  Visualization of peripheral nerve degeneration and regeneration: monitoring with diffusion tensor tractography.

Authors:  Takehiko Takagi; Masaya Nakamura; Masayuki Yamada; Keigo Hikishima; Suketaka Momoshima; Kanehiro Fujiyoshi; Shinsuke Shibata; Hirotaka James Okano; Yoshiaki Toyama; Hideyuki Okano
Journal:  Neuroimage       Date:  2008-10-02       Impact factor: 6.556

4.  Injection injury of the sciatic nerve (370 cases).

Authors:  F J Villarejo; A M Pascual
Journal:  Childs Nerv Syst       Date:  1993-07       Impact factor: 1.475

Review 5.  Complications of regional anesthesia.

Authors:  J Eric Greensmith; W Bosseau Murray
Journal:  Curr Opin Anaesthesiol       Date:  2006-10       Impact factor: 2.706

6.  Iatrogenic sciatic nerve injuries at buttock and thigh levels: the Louisiana State University experience review.

Authors:  Esmiralda Yeremeyeva; David G Kline; Daniel H Kim
Journal:  Neurosurgery       Date:  2009-10       Impact factor: 4.654

7.  Diffusion tensor imaging to assess axonal regeneration in peripheral nerves.

Authors:  Helmar C Lehmann; Jiangyang Zhang; Susumu Mori; Kazim A Sheikh
Journal:  Exp Neurol       Date:  2009-10-29       Impact factor: 5.330

8.  Sciatic nerve injection palsy in the child: early microsurgical treatment and long-term results.

Authors:  Filippo M Senes; Riccardo Campus; Flavio Becchetti; Nunzio Catena
Journal:  Microsurgery       Date:  2009       Impact factor: 2.425

9.  Sciatic Nerve Injection Palsy in Children, Electrophysiologic Pattern and Outcome: A Case Series Study.

Authors:  Vahideh Toopchizadeh; Mohammad Barzegar; Afshin Habibzadeh
Journal:  Iran J Child Neurol       Date:  2015

10.  Injection nerve palsy: What's to blame?

Authors:  James M Barry; Viraat Harsh; Anil Kumar; Shashikant Patil
Journal:  J Neurosci Rural Pract       Date:  2013-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.